Delivery Order SPE2DB22D2009-SPE2DB25FL9GD
Award Date
5/16/25
Potential Completion Date
5/19/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of METHOTREXATE 2.5 MG TABLET UD 20S, a pharmaceutical product, to support military healthcare programs. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $1,493.54. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Methotrexate 2.5 mg tablets. The delivery order has a ceiling value of $1,906.78 and an ultimate completion date of September 11, 2024. The contract is a firm-fixed price type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support the healthcare needs of military treatment facilities and other...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The order is for METHOTREXATE 2.5 MG TABLET UD 20S, a pharmaceutical product. The delivery order has a ceiling value of $2,244.67 and an ultimate completion date of March 21, 2024. AmerisourceBergen Drug Corp is a for-profit organization that serves as a prime contractor providing a wide range of...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,384.44 fixed-price delivery order is for 4,567,222,526 units of Methotrexate 2.5 mg tablets. The contract has a completion date of February 11, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Methotrexate 2.5 mg tablets, a medication used to treat various conditions. The contract has a ceiling value of $25,727.25 and an ultimate completion date of December 4, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor in the United States. The contract is for the delivery of 4,565,633,861 units of 2.5 mg methotrexate tablets in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,294.93 and an ultimate completion date of August 30, 2024. This contract is not a set-aside and is part of a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,820.90, is for the delivery of 4560843534 - METHOTREXATE 2.5 MG TABLET 100S. It is a firm fixed price, delivery order contract with a completion date of May 8, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB22D2009|SPE2DB25FL8VR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania. The contract is for the delivery of Methotrexate 2.5 mg tablets, a medication used to treat various conditions, and has a ceiling value of $3,779.10. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,015.22 Firm Fixed Price contract is for the delivery of 4,560,862,883 units of Methotrexate 2.5 mg tablets. The contract has an ultimate completion date of May 9, 2023 and is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,826.37 firm fixed-price contract is for the delivery of Methotrexate 2.5 mg tablets, with a completion date of July 3, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables...